Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The 3q25 rs2305619 Polymorphism is Associated With Coronary Microvascular Obstruction Following Primary Angioplasty for Acute ST-segment Elevation Myocardial Infarction

NCT03907722 is registered in ClinicalTrials.gov with Indonesian Cardiovascular Research Center as lead sponsor.

NCT NCT03907722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03907722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The 3q25 rs2305619 Polymorphism is Associated With Coronary Microvascular Obstruction Following Primary Angioplasty for Acute ST-segment Elevation Myocardial Infarction
Lead sponsor
Indonesian Cardiovascular Research Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
September 3, 2018
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

microvascular coronary artery disease, stemi